Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

被引：87

作者：

Green, Damian J. ^{[1
,2
]}

Pont, Margot ^{[3
]}

Sather, Blythe Duke ^{[4
]}

Cowan, Andrew J. ^{[3
,5
]}

Turtle, Cameron J. ^{[1
,6
]}

Till, Brian G. ^{[1
,2
]}

Nagengast, Anne M. ^{[3
]}

Libby, Edward N., III ^{[7
]}

Becker, Pamela S. ^{[3
,8
]}

Coffey, David G. ^{[1
,2
]}

Tuazon, Sherilyn A. ^{[2
,9
]}

Wood, Brent ^{[10
,11
]}

Blake, Michelle ^{[4
]}

Works, Melissa ^{[4
]}

Thompson, Bruce S. ^{[3
]}

Gooley, Ted ^{[2
]}

Appelbaum, Frederick R. ^{[2
,12
]}

Maloney, David G. ^{[1
,2
]}

Riddell, Stanley R. ^{[1
,2
]}

机构：

[1] Univ Washington, Dept Med, Seattle, WA USA

[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA

[3] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[4] Juno Therapeut, Seattle, WA USA

[5] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA

[6] Seattle Canc Care Alliance, Seattle, WA USA

[7] Univ Washington, Med Oncol, Seattle, WA 98195 USA

[8] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA

[9] Univ Washington, Dept Hematol & Med Oncol, Seattle, WA 98195 USA

[10] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA

[11] Univ Washington, Dept Pathol, Seattle, WA 98195 USA

[12] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-117729

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1011

引用

页数：3